Shnayder, N.A.,
Novitsky, M.A.,
Neznanov, N.G.,
Limankin, O.V.,
Asadullin, A.R.,
Petrov, A.V.,
Dmitrenko, D.V.,
Narodova, E.A.,
Popenko, N.V.,
Nasyrova, R.F. (2022) and clinical predictors and a personalized
therapy strategy for schizophrenia. However, it should be recognized
Vaiman, E.E.,
Shnayder, N.A.,
Zhuravlev, N.M.,
Petrova, M.M.,
Asadullin, A.R.,
Al-Zamil, M.,
Garganeeva, N.R.,
Shipulin, G.A.,
Cumming, G.,
Nasyrova, R.F. (2022) of which is influenced by modifying factors (APs’ dose, duration of APs
therapy,
APs polytherapy
for developing targeted
therapy for neurological consequences of COVID-19 using miRNAs, since epigenetic changes
Mukhametov, Ural,
Lyulin, Sergey,
Borzunov, Dmitry,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Sufianov, Albert (2023) to improving patient outcomes through the development of new
therapies and improved resuscitation strategies
СРАВНИТЕЛЬНЫЙ АНАЛИЗ РЕЗУЛЬТАТОВ ОПЕРАТИВНОГО ЛЕЧЕНИЯ СТРИКТУР УРЕТРЫ С ОЦЕНКОЙ МИКРОЦИРКУЛЯТОРНОГО РУСЛАВ.Н. Павлов,
V.N. Pavlov,
Р. А. Казихинуров,
R. A. Kazikhinurov,
А. А. Казихинуров,
A. A. Kazikhinurov,
А. Р. Фарганов,
A. R. Farganov,
Т. Х. Акчулпанов,
T. Kh. Akchulpanov,
И. В. Музафаров,
I. V. Muzafarov (Медицинский вестник Башкортостана, №3, 2017) COMPARATIVE ANALYSIS OF URETHRA STRICTURE OPERATIVE
THERAPY RESULTS WITH MICROVASCULATURE